revenue growth

Virbac delivers 7.9% revenue growth and 16.3% adjusted EBIT margin in 2025, demonstrating strong operational execution amid robust product momentum.

SentinelOne, an AI-powered cybersecurity vendor, hit $1 billion revenue in fiscal 2026 with improving profitability. Trading under $15, analysts target $19.23 (45% upside) citing 4.7x price-to-sales valuation discount versus peers and $100+ billion market opportunity.

SentinelOne crossed $1B revenue and achieved operating profitability, yet stock fell on conservative Q1 guidance. Options traders signal bullish conviction amid potential overreaction.

ESLT stock jumped 12% after Q4 results showed $2.1B revenue and record $28.1B backlog, with robust C4I and intelligence segment growth offsetting aerospace weakness.

Adobe stock down 25% YTD despite double-digit growth, record cash flow, and strong AI momentum. Depressed valuation suggests significant overreaction.

$KRAT surges 20% after Q4 earnings beat: $115.6M sales (+13.7% YoY), $7.2M net income (+22.8%), eco-friendly products hit 37.3% of revenue.

Team Inc. reports 8.5% revenue growth to $20M and 12.4% adjusted EBITDA growth. Company refinances debt, cuts rates 100+ bps, targets $10M in annual savings.

Beaten-down retailers Chewy and Target present potential doubling opportunities through business expansion and operational turnaround initiatives, though execution risks remain significant.

Security National Financial reports 10.8% earnings growth to $32.2M in 2025, with revenues rising 3% to $344.6M across all three business segments.

Broadcom projects 80% upside to $614 by 2027 on $100B AI chip revenue and $17.54 EPS, offering leveraged exposure to AI infrastructure spending growth.

Broadcom accelerates AI ambitions with custom XPU chips and 100%+ revenue growth to $8.4B, targeting $100B+ in AI revenue by 2027.

Chewy stock fell 23% in 2026 despite solid 8.3% revenue and 4.9% customer growth, but its P/E of 52 remains expensive versus market average of 29, limiting buying appeal.

Palantir's 70% growth masks 240x P/E valuation and slowing contract growth. Amazon offers superior risk-reward with 24% AWS growth and 29x P/E.

Vertex Pharmaceuticals eyes 25% stock upside to $600 as it expands beyond cystic fibrosis with new drug approvals and kidney disease candidate povetacicept.

MIG Capital trims $37.4M Sotera Health stake while maintaining significant position. Company posts record profits, 20-year revenue growth streak amid 18% annual share price gain.

Veeva Systems delivered 13.6% CAGR returns since 2013 IPO. Strong competitive advantages and $20B addressable market could support multimillion-dollar returns, but growth is slowing amid increasing competition.

Nvidia invests $2 billion in Nebius, backing AI data center expansion with access to next-gen chips. Revenue expected to surge 531% to $3.35B in 2026.

JPMorgan reiterates Overweight on $ZG, citing durable software and data advantages. Zillow plans $1.25B buyback, projects 15% revenue growth in 2026.

Nebius Group surged 333% annually with Wall Street projecting 36-58% further gains. The neocloud AI data center operator plans massive capacity expansion amid soaring infrastructure demand.

Investment firm 13D Management purchased 52,000 $WK shares worth $4.49M, signaling bullish sentiment despite year-long stock decline amid AI concerns.